Press Releases

Hogan Lovells advises Gilead Sciences in long-acting HIV therapy collaboration agreement with Merck

Northern Virginia, Washington D.C., Brussels, 17 March 2021 – A team from global law firm Hogan Lovells has advised Gilead Sciences on its recently announced collaboration agreement with...

Press Releases

Hogan Lovells welcomes the New Year and 25 new partner and 60 new counsel promotions

LONDON and WASHINGTON, D.C., 5 January 2021 – Global law firm Hogan Lovells today announced that 25 of its people have been promoted to partner effective 1 January across a network of ...

Awards and Rankings

Hogan Lovells listed in The Times Best Law Firms 2021

The Times has listed Hogan Lovells among England and Wales' top law firms in its Best Law Firms guide, for the third consecutive year.

Press Releases

Hogan Lovells represents Gilead Sciences and Kite Pharma in collaboration and license agreement with oNKo-innate Pty. Ltd.

Northern Virginia, 24 April, 2020 – Hogan Lovells represented biopharmaceutical companies Gilead Sciences and Kite Pharma in their cancer immunotherapy research collaboration with...

Press Releases

Hogan Lovells appoints TMT/Privacy specialist, Etienne Drouard into the Paris office

3 February 2020 - Hogan Lovells announced today that Etienne Drouard will be joining the firm as a Commercial partner, based in the Paris office. He is one of the most prominent lawyers in...

Press Releases

Hogan Lovells advises ESTEVE on the acquisition of Riemser

Led by partners Daniel Dehghanian and Jörg Schickert international law firm Hogan Lovells has advised Barcelona-based, global pharmaceutical company ESTEVE on its acquisition of German ...

Press Releases

Hogan Lovells announces 10 GB Para-athletes awarded 2018 -19 bursary

In the run-up to the Tokyo 2020 Summer Paralympic Games, Hogan Lovells today announces the recipients of its second annual GB Para-Athlete Bursary to support aspiring Paralympians.

Loading data